Cargando…

Severe Hyperprolactinemia during Lurasidone Treatment in a 16-year Old Girl with Schizophrenia – A Case Report

BACKGROUND: Increase of serum prolactin is a common adverse effect to antipsychotic medication, potentially leading to galactorrhea, menstrual cycle disturbances or sexual adverse effects. Lurasidone is commonly associated with a low risk of prolactin change. OBJECTIVE: To describe a case of severe...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gjessing Jensen, Karsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284940/ https://www.ncbi.nlm.nih.gov/pubmed/35903553 http://dx.doi.org/10.2478/sjcapp-2022-0009

Ejemplares similares

Lurasidone-induced Parkinsonism and Hyperprolactinemia
por: Suthar, Navratan, et al.
Publicado: (2019)

Clinical potential of lurasidone in the management of schizophrenia
por: Samalin, Ludovic, et al.
Publicado: (2011)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia, Silvio, et al.
Publicado: (2012)

Hyperprolactinemia associated with macroprolactinoma in a 17-year-old: A case report
por: Czyzyk, Adam, et al.
Publicado: (2019)

A 12-Year-Old Girl with Juvenile Granulosa Cell Tumor of the Ovary, Presenting with Adolescent Hyperprolactinemia, Galactorrhea, and Amenorrhea
por: Park, Hyunsoo, et al.
Publicado: (2023)

The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey, Philip D
Publicado: (2015)

Identification of clinical phenotypes in schizophrenia: the role of lurasidone
por: Riva, Marco Andrea, et al.
Publicado: (2021)

Lurasidone for the treatment of schizophrenia in adult and paediatric populations
por: Guilera, Teresa, et al.
Publicado: (2023)

Lurasidone in adolescents with schizophrenia: Sustained remission and recovery during 2 years of open-label treatment
por: Tocco, M., et al.
Publicado: (2021)

Schizophrenia relapse, patient considerations, and potential role of lurasidone
por: Citrome, Leslie
Publicado: (2016)

Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
por: Javed, Afzal, et al.
Publicado: (2019)

Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia
por: Meltzer, Herbert Y., et al.
Publicado: (2020)

Lurasidone Augmentation of Clozapine in Schizophrenia—Retrospective Chart Review
por: Siwek, Marcin, et al.
Publicado: (2023)

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
por: Miura, Itaru, et al.
Publicado: (2023)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
por: Yasui-Furukori, Norio
Publicado: (2012)

Plexiform neurofibroma in a 16-year-old girl
por: Anand, Reena, et al.
Publicado: (2015)

Fibromatous Uterus in a 16-Year-Old Girl: A Case Report
por: Tsili, Athina C., et al.
Publicado: (2010)

Neutrocytopenia associated with a lurasidon therapy in a patient with paranoid schizophrenia
por: Mielczarek, Z., et al.
Publicado: (2023)

Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
por: Rajagopalan, Krithika, et al.
Publicado: (2016)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
por: Ogasa, Masaaki, et al.
Publicado: (2012)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

Lurasidone augmentation to clozapine in treatment resistant schizophrenia: A pilot study
por: Arienti, V., et al.
Publicado: (2023)

Recurrent abdominal pain in a 16-year-old girl
por: Mohan, Pazhanivel, et al.
Publicado: (2011)

Neutropenia in a schizophrenia patient following combined lurasidone and paliperidone therapy: a case report
por: Mielczarek, Zuzanna, et al.
Publicado: (2023)

Clinical manifestations, evaluation and management of hyperprolactinemia in adolescent and young girls: a brief review
por: Michail, Matalliotakis, et al.
Publicado: (2019)

Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China
por: Liu, Jia, et al.
Publicado: (2022)

Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice
por: Fagiolini, Andrea, et al.
Publicado: (2022)

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
por: Thomas, Jennifer E., et al.
Publicado: (2015)

A network meta-analysis of the dose–response effects of lurasidone on acute schizophrenia
por: Srisurapanont, Manit, et al.
Publicado: (2021)

Orbital roof intradiploic meningioma in a 16-year-old girl
por: Verma, Satish Kumar, et al.
Publicado: (2015)

A 16-Year-Old Girl with Acute Onset Respiratory Distress
por: Safari, Saeed, et al.
Publicado: (2014)

Vitrectomy for vitreopapillary traction in a nondiabetic 16-year-old girl
por: Nagesha, C. K., et al.
Publicado: (2017)

Lurasidone-induced mania: A case report
por: Fernández, T., et al.
Publicado: (2022)

Intracerebral Schwannoma in a 16-Year-Old Girl: A Case Report and Review of the Literature
por: Srinivas, R., et al.
Publicado: (2013)

Amyloidosis Cutis Dyschromica in a 16-Year-Old Filipino Girl: A Case Report
por: Bautista, Fendi EJ R., et al.
Publicado: (2022)

Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia
por: Meyer, Jonathan M., et al.
Publicado: (2015)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_trddu9e9sr2lp3nm1tlp9cfitf